Skip to main content

Synthetic Conjugated Estrogen Shortage

Last Updated: August 5, 2016
Status: Discontinued

Products Affected - Description
    • Enjuvia tablet, Teva, 0.3 mg, 100 count, NDC 51285-0406-02
    • Enjuvia tablet, Teva, 0.45 mg, 100 count, NDC 51285-0407-02
    • Enjuvia tablet, Teva, 0.625 mg, 100 count, NDC 51285-0408-02
    • Enjuvia tablet, Teva, 0.9 mg, 100 count, NDC 51285-0409-02
    • Enjuvia tablet, Teva, 1.25 mg, 100 count, NDC 51285-0410-02
Reason for the Shortage
    • Teva discontinued Cenestin in late-August 2014.
    • Premarin is not affected by this shortage.
    • Teva discontinued Enjuvia in mid-2106.

Estimated Resupply Dates

    • Teva has discontinued all Enjuvia presentations.

Updated

Updated August 5, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 6, 2014 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer